Hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies: Safety and efficacy of desensitization.

Rosalaura V Villarreal González Sandra Nora González-Díaz Oscar Vidal-GutiérrezCarlos de la Cruz-de la CruzDiana C Pérez-IbaveMaría L Garza-Rodríguez

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

The diagnosis of hypersensitivity reaction to anticancer chemotherapy and monoclonal antibodies offers a panorama in the management of oncological diseases. Our standardized desensitization protocol is safe and effective and can be reproduced in other centers to treat patients who need to maintain first-line treatment.

Keyphrases

locally advanced
rectal cancer
drug induced
randomized controlled trial
prostate cancer
radical prostatectomy
chemotherapy induced
radiation therapy
robot assisted